1. Home
  2. STVN vs PEGA Comparison

STVN vs PEGA Comparison

Compare STVN & PEGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • PEGA
  • Stock Information
  • Founded
  • STVN 1949
  • PEGA 1983
  • Country
  • STVN Italy
  • PEGA United States
  • Employees
  • STVN N/A
  • PEGA N/A
  • Industry
  • STVN Containers/Packaging
  • PEGA EDP Services
  • Sector
  • STVN Consumer Discretionary
  • PEGA Technology
  • Exchange
  • STVN Nasdaq
  • PEGA Nasdaq
  • Market Cap
  • STVN 6.3B
  • PEGA 4.9B
  • IPO Year
  • STVN 2021
  • PEGA 1996
  • Fundamental
  • Price
  • STVN $21.30
  • PEGA $68.59
  • Analyst Decision
  • STVN Buy
  • PEGA Buy
  • Analyst Count
  • STVN 5
  • PEGA 10
  • Target Price
  • STVN $30.60
  • PEGA $82.60
  • AVG Volume (30 Days)
  • STVN 386.4K
  • PEGA 632.5K
  • Earning Date
  • STVN 10-29-2024
  • PEGA 10-23-2024
  • Dividend Yield
  • STVN 0.27%
  • PEGA 0.17%
  • EPS Growth
  • STVN N/A
  • PEGA N/A
  • EPS
  • STVN 0.49
  • PEGA 1.45
  • Revenue
  • STVN $1,165,359,477.00
  • PEGA $1,490,176,000.00
  • Revenue This Year
  • STVN $2.82
  • PEGA $5.54
  • Revenue Next Year
  • STVN $9.77
  • PEGA $6.81
  • P/E Ratio
  • STVN $43.54
  • PEGA $47.39
  • Revenue Growth
  • STVN 5.53
  • PEGA 15.43
  • 52 Week Low
  • STVN $16.56
  • PEGA $37.66
  • 52 Week High
  • STVN $35.56
  • PEGA $72.74
  • Technical
  • Relative Strength Index (RSI)
  • STVN 57.54
  • PEGA 53.28
  • Support Level
  • STVN $20.68
  • PEGA $65.76
  • Resistance Level
  • STVN $23.20
  • PEGA $71.24
  • Average True Range (ATR)
  • STVN 1.19
  • PEGA 1.91
  • MACD
  • STVN 0.20
  • PEGA -0.25
  • Stochastic Oscillator
  • STVN 60.74
  • PEGA 46.47

About STVN Stevanato Group S.p.A.

Stevanato Group SPA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About PEGA Pegasystems Inc.

Founded in 1983, Pegasystems provides a suite of solutions for customer engagement and business process management. The company's key offering is the Pega Infinity platform, which combines business process management, or BPM, with customer relationship management, or CRM, applications. The company focuses on enterprise-size customers, specifically within the financial, insurance, and healthcare verticals.

Share on Social Networks: